Maternal Stress on Human Milk and Infant Outcomes
Launched by UNIVERSITY OF IDAHO · Mar 26, 2021
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how stress affects new mothers who have had preterm infants (babies born before 36 weeks of pregnancy). The study is testing an 8-week program designed to help mothers practice mindfulness and self-compassion, which means being kinder to themselves. Researchers hope that by reducing stress and increasing self-compassion, the quality of the milk produced by these mothers will improve, leading to better health outcomes for their babies.
To participate in this study, mothers must be caring for a preterm infant who is being treated at Oregon Health and Sciences University. There are no specific exclusions mentioned, so if you meet the criteria, you might be eligible to join. Participants can expect to engage in mindfulness activities over the course of eight weeks, and the study aims to see how these activities might positively impact both the mothers and their infants.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Mothers of newborn infants at Kootenai Health NICU and the Palouse region
- Exclusion Criteria:
- • -
About University Of Idaho
The University of Idaho, a leading research institution located in Moscow, Idaho, is dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its robust academic resources and multidisciplinary expertise to conduct rigorous research aimed at improving patient outcomes and public health. Committed to ethical standards and scientific integrity, the University of Idaho collaborates with healthcare professionals, researchers, and community partners to explore novel therapeutic interventions and enhance evidence-based practices. Through its clinical trials, the university seeks to contribute valuable insights to the medical community and foster advancements in healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Coeur D'alene, Idaho, United States
Patients applied
Trial Officials
Yimin Chen, PhD
Principal Investigator
University of Idaho
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials